Presenilin-1 polymorphism in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia in Japanese population

Acta Neurol Scand. 1996 Nov;94(5):326-8. doi: 10.1111/j.1600-0404.1996.tb07074.x.

Abstract

We investigated the genetic association between intronic polymorphism in Presenilin-1 (PS-1) gene and patients with various types of dementia such as Alzheimer's disease (AD), vascular dementia (VD) and alcohol associated dementia (ALD), in Japanese population. Homozygosity for allele 1 of the PS-1 polymorphism was significantly increased in late-onset sporadic AD, but not in early-onset sporadic AD, familial AD, VD and ALD. When late-onset sporadic AD patients were divided on the basis of apolipoprotein E (APOE) genotype, homozygosity for the allele 1 of the PS-1 polymorphism was significantly increased in patients with late-onset sporadic AD without APOE epsilon 4 allele, but not in those with APOE epsilon 4 allele. Intronic mutation in PS-1 gene may be specific and one of the genetic risk factor for late-onset sporadic AD.

MeSH terms

  • Age of Onset
  • Aged
  • Alcoholism / complications*
  • Alleles
  • Alzheimer Disease / genetics*
  • Dementia / chemically induced*
  • Dementia / genetics*
  • Dementia, Vascular / genetics*
  • Female
  • Genotype
  • Homozygote
  • Humans
  • Japan
  • Male
  • Membrane Proteins / genetics*
  • Polymorphism, Genetic
  • Presenilin-1

Substances

  • Membrane Proteins
  • PSEN1 protein, human
  • Presenilin-1